Brain scans reveal how a common drug may help teens with autism
NCT ID NCT06826326
First seen Feb 21, 2026 · Last updated May 19, 2026 · Updated 9 times
Summary
This study looks at how a single dose of escitalopram (Lexapro) changes brain activity in teens aged 12-17 with autism. Five participants will have brain scans while doing a reward-based eye-tracking task after taking the drug or a placebo. The goal is to understand how the drug affects brain networks linked to rigid thinking and repetitive behaviors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hoglund Biomedical Imaging Center
Kansas City, Kansas, 66103, United States
Conditions
Explore the condition pages connected to this study.